Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian Mitchell

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Asia-Pacific Journal of Clinical Oncology|April 25, 2012
Triple-negative breast cancer: making the most of a misnomerNicole McCarthy, Gillian Mitchell, Michael Bilous, et al.
The Lancet. Oncology|August 27, 2011
The tubal hypothesis of ovarian cancer: caution neededIan M Collins, Susan M Domchek, David G Huntsman, et al.
Gynecologic Oncology Research and Practice|May 28, 2016
Opportunistic salpingectomy for ovarian cancer preventionGillian E Hanley, Jessica N McAlpine, Janice S Kwon, et al.
Journal of Ovarian Research|April 17, 2013
No evidence for PALB2 methylation in high-grade serous ovarian cancerThomas Mikeska, Kathryn Alsop, , et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 15, 2018
Heterogeneity and Uncertainties Specific to Genome-Based Health Technological AssessmentsLara Petelin, Danny Liew, Gillian Mitchell, et al.
Asia-Pacific Journal of Clinical Oncology|September 3, 2011
The role of poly adenosine diphosphate ribose polymerase inhibitors in breast and ovarian cancer: current status and future directionsFiona Chionh, Gillian Mitchell, Geoffrey J Lindeman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 12, 2018
Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic reviewLara Petelin, Alison H Trainer, Gillian Mitchell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 27, 2010
Moving toward personalized medicine: treatment-focused genetic testing of women newly diagnosed with ovarian cancerAlison H Trainer, Bettina Meiser, Kaaren Watts, et al.
Familial Cancer|April 6, 2012
The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopauseCarmel Pezaro, Paul James, Joanne McKinley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 21, 2019
A Microsimulation Model for Evaluating the Effectiveness of Cancer Risk Management for BRCA Pathogenic Variant Carriers: miBRovaCAreLara Petelin, Lucinda Hossack, Gillian Mitchell, et al.
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Asia-Pacific Journal of Clinical Oncology|April 25, 2012
Triple-negative breast cancer: making the most of a misnomerNicole McCarthy, Gillian Mitchell, Michael Bilous, et al.
The Lancet. Oncology|August 27, 2011
The tubal hypothesis of ovarian cancer: caution neededIan M Collins, Susan M Domchek, David G Huntsman, et al.
Gynecologic Oncology Research and Practice|May 28, 2016
Opportunistic salpingectomy for ovarian cancer preventionGillian E Hanley, Jessica N McAlpine, Janice S Kwon, et al.
Journal of Ovarian Research|April 17, 2013
No evidence for PALB2 methylation in high-grade serous ovarian cancerThomas Mikeska, Kathryn Alsop, , et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 15, 2018
Heterogeneity and Uncertainties Specific to Genome-Based Health Technological AssessmentsLara Petelin, Danny Liew, Gillian Mitchell, et al.
Asia-Pacific Journal of Clinical Oncology|September 3, 2011
The role of poly adenosine diphosphate ribose polymerase inhibitors in breast and ovarian cancer: current status and future directionsFiona Chionh, Gillian Mitchell, Geoffrey J Lindeman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 12, 2018
Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic reviewLara Petelin, Alison H Trainer, Gillian Mitchell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 27, 2010
Moving toward personalized medicine: treatment-focused genetic testing of women newly diagnosed with ovarian cancerAlison H Trainer, Bettina Meiser, Kaaren Watts, et al.
Familial Cancer|April 6, 2012
The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopauseCarmel Pezaro, Paul James, Joanne McKinley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 21, 2019
A Microsimulation Model for Evaluating the Effectiveness of Cancer Risk Management for BRCA Pathogenic Variant Carriers: miBRovaCAreLara Petelin, Lucinda Hossack, Gillian Mitchell, et al.
Pageof 12